AU6274896A - Stable copper(i) complexes as active therapeutic substances - Google Patents

Stable copper(i) complexes as active therapeutic substances

Info

Publication number
AU6274896A
AU6274896A AU62748/96A AU6274896A AU6274896A AU 6274896 A AU6274896 A AU 6274896A AU 62748/96 A AU62748/96 A AU 62748/96A AU 6274896 A AU6274896 A AU 6274896A AU 6274896 A AU6274896 A AU 6274896A
Authority
AU
Australia
Prior art keywords
complexes
active therapeutic
therapeutic substances
stable copper
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62748/96A
Inventor
Andrew Branca
Thomas M Marschner
Alexander J Pallenberg
Leonard M Patt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyte Corp
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Publication of AU6274896A publication Critical patent/AU6274896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62748/96A 1995-06-06 1996-06-06 Stable copper(i) complexes as active therapeutic substances Abandoned AU6274896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46864595A 1995-06-06 1995-06-06
PCT/US1996/010122 WO1996039144A1 (en) 1995-06-06 1996-06-06 Stable copper(i) complexes as active therapeutic substances
US468645 1999-12-21

Publications (1)

Publication Number Publication Date
AU6274896A true AU6274896A (en) 1996-12-24

Family

ID=23860638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62748/96A Abandoned AU6274896A (en) 1995-06-06 1996-06-06 Stable copper(i) complexes as active therapeutic substances

Country Status (2)

Country Link
AU (1) AU6274896A (en)
WO (1) WO1996039144A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
AU753657B2 (en) * 1997-10-22 2002-10-24 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and cerebrovascular disease
WO1999030721A1 (en) * 1997-12-17 1999-06-24 Cornell Research Foundation, Inc. Cyclooxygenase-2 inhibition
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
JP5723155B2 (en) * 2008-09-03 2015-05-27 株式会社Ｎｂｃメッシュテック Antiviral agent
JP5570006B2 (en) * 2009-12-24 2014-08-13 国立大学法人 東京大学 Virus inactivating agent
WO2012129237A2 (en) 2011-03-20 2012-09-27 Trustees Of Boston University Therapeutic agent for emphysema and copd
RU2682674C2 (en) * 2013-03-15 2019-03-20 Шерри Энн МАКФАРЛЭНД Metal-based coordination complexes as photodynamic compounds and use thereof
CN104922111B (en) * 2015-04-13 2017-08-29 中山大学 A kind of application of micromolecular compound in anti-influenza virus medicament
CN112587650A (en) * 2021-01-19 2021-04-02 中日友好医院(中日友好临床医学研究所) Short peptide and medical application of copper ion chelate thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU498201B2 (en) * 1973-11-12 1979-02-22 Shulman, A. Contraceptive or antivenereal agent
WO1992015329A1 (en) * 1991-02-28 1992-09-17 The United States Of America, Represented By The Secretary, United States Department Of Commerce Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
TW239077B (en) * 1993-06-02 1995-01-21 Procyte Corp

Also Published As

Publication number Publication date
WO1996039144A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU6602196A (en) Electrode catheter
AU6497696A (en) Electrode
AU1271597A (en) Modular physiological computer-recorder
AU7572196A (en) Pharmaceutical formulations
AU7590096A (en) Drug composition
AU5568694A (en) Stable oligonucleotides
AU8495998A (en) Improved dosage units
AU2270695A (en) Active compounds
AU5759796A (en) Table-top connector
AU7184994A (en) Imidazole derivatives as therapeutic agents
AU6165196A (en) Stable formulations of mhc-peptide complexes
AU6138396A (en) Stable plasmin solution
AU3105495A (en) Electrical connector for therapeutic devices
AU6274896A (en) Stable copper(i) complexes as active therapeutic substances
AU7604096A (en) Gameboard
AU5907096A (en) Chemical complexes
AU5693596A (en) Active compound combinations
AU4786696A (en) Connectors
AU6130196A (en) Cell treatment
AU5998696A (en) Fungicidal active agent combinations
AUPN727595A0 (en) Therapeutic compositions
AU4786596A (en) Connectors
AU1093697A (en) Active bio-compounds